-
1Academic Journal
Συγγραφείς: E. S. Fedenko, I. N. Zakharova, O. V. Zaytseva, A. N. Pampura, O. B. Tamrazova, Е. С. Феденко, И. Н. Захарова, О. В. Зайцева, А. Н. Пампура, О. Б. Тамразова
Πηγή: Meditsinskiy sovet = Medical Council; № 17 (2023); 172-178 ; Медицинский Совет; № 17 (2023); 172-178 ; 2658-5790 ; 2079-701X
Θεματικοί όροι: чрескожная сенсибилизация, emollients, epidermal barrier, pollen allergy, cutaneous sensitization, эмоленты, эпидермальный барьер, пыльцевая аллергия
Περιγραφή αρχείου: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7837/6958; Кубанов АА, Намазова-Баранова ЛС, Хаитов РМ, Ильина НИ, Алексеева ЕА, Амбарчян ЭТ и др. Атопический дерматит: клинические рекомендации. М.; 2021. 81 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/265_2.; Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015;66(Suppl. 1):8–16. https://doi.org/10.1159/000370220.; Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int J Clin Pract. 2006;60(8):984–992. https://doi.org/10.1111/j.1742-1241.2006.01047.x.; Liang Y, Chang C, Lu Q. The Genetics and Epigenetics of Atopic DermatitisFilaggrin and Other Polymorphisms. Clin Rev Allergy Immunol. 2016;51(3):315–328. https://doi.org/10.1007/s12016-015-8508-5.; Birben E, Sackesen C, Turgutoğlu N, Kalayci O. The role of SPINK5 in asthma related physiological events in the airway epithelium. Respir Med. 2012;106(3):349–355. https://doi.org/10.1016/j.rmed.2011.11.007.; Egawa G, Kabashima K. Barrier dysfunction in the skin allergy. Allergol Int. 2018;67(1):3–11. https://doi.org/10.1016/j.alit.2017.10.002.; Ständer S. Atopic Dermatitis. N Engl J Med. 2021;384(12):1136–1143. https://doi.org/10.1056/NEJMra2023911.; Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324–338. https://doi.org/10.1007/s12016-021-08880-3.; Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017;13(1):15–26. https://doi.org/10.1080/1744666X.2016.1212660.; Hostetler SG, Kaffenberger B, Hostetler T, Zirwas MJ. The role of airborne proteins in atopic dermatitis. J Clin Aesthet Dermatol. 2010;3(1):22–31. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921737/.; Serhan N, Basso L, Sibilano R, Petitfils C, Meixiong J, Bonnart C et al. House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol. 2019;20(11):1435–1443. https://doi.org/10.1038/s41590-019-0493-z.; Werfel T, Heratizadeh A, Niebuhr M, Kapp A, Roesner LM, Karch A et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96–103.e9. https://doi.org/10.1016/j.jaci.2015.04.015.; Fölster-Holst R, Galecka J, Weißmantel S, Dickschat U, Rippke F, Bohnsack K et al. Birch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study. Clin Cosmet Investig Dermatol. 2015;8:539–548. https://doi.org/10.2147/CCID.S81700.; Knaysi G, Smith AR, Wilson JM, Wisniewski JA. The Skin as a Route of Allergen Exposure: Part II. Allergens and Role of the Microbiome and Environmental Exposures. Curr Allergy Asthma Rep. 2017;17(1):7. https://doi.org/10.1007/s11882-017-0675-4.; Brough HA, Nadeau KC, Sindher SB, Alkotob SS, Chan S, Bahnson HT et al. Epicutaneous sensitization in the development of food allergy: What is the evidence and how can this be prevented? Allergy. 2020;75(9):2185–2205. https://doi.org/10.1111/all.14304.; Strid J, Hourihane J, Kimber I, Callard R, Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol. 2004;34(8):2100–2109. https://doi.org/10.1002/eji.200425196.; Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680. https://doi.org/10.1038/ni805.; Oyoshi MK, Larson RP, Ziegler SF, Geha RS. Mechanical injury polarizes skin dendritic cells to elicit a T(H)2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976–984. https://doi.org/10.1016/j.jaci.2010.08.041.; Tordesillas L, Goswami R, Benedé S, Grishina G, Dunkin D, Järvinen KM et al. Skin exposure promotes a Th2-dependent sensitization to peanut allergens. J Clin Invest. 2014;124(11):4965–4975. https://doi.org/10.1172/JCI75660.; Komai-Koma M, Brombacher F, Pushparaj PN, Arendse B, McSharry C, Alexander J et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice. Allergy. 2012;67(9):1118–1126. https://doi.org/10.1111/j.1398-9995.2012.02859.x.; Wassmann-Otto A, Heratizadeh A, Wichmann K, Werfel T. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy. 2018;73(10):2046–2054. https://doi.org/10.1111/all.13454.; Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104(2 Pt 1):466–472. https://doi.org/10.1016/s0091-6749(99)70395-7.; De Bruin-Weller M, Gadkari A, Auziere S, Simpson EL, Puig L, Barbarot S et al. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada. J Eur Acad Dermatol Venereol. 2020;34(5):1026–1036. https://doi.org/10.1111/jdv.16003.; Wollenberg A, Barbarot S, Bieber T, Christen-Zaech S, Deleuran M, FinkWagner A et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32(5):657–682. https://doi.org/10.1111/jdv.14891.; Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71(1):116–132. https://doi.org/10.1016/j.jaad.2014.03.023.; Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060. https://doi.org/10.1111/j.1468-3083.2012.04635.x.; Giménez-Arnau A. Standards for the Protection of Skin Barrier Function. In: Agner T (ed.). Skin Barrier Function. Karger; 2016, pp. 123–134. https://doi.org/10.1159/000441588.; Guéniche A, Dahel K, Bastien P, Martin R, Nicolas JF, Breton L. Vitreoscilla filiformis bacterial extract to improve the efficacy of emollient used in atopic dermatitis symptoms. J Eur Acad Dermatol Venereol. 2008;22(6):746–747. https://doi.org/10.1111/j.1468-3083.2007.02428.x.; Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a prospective, randomized, double-blind, placebocontrolled clinical study. Br J Dermatol. 2008;159(6):1357–1363. https://doi.org/10.1111/j.1365-2133.2008.08836.x.; Mainzer C, Le Guillou M, Vyumvuhore R, Chadoutaud B, Bordes S, Closs B. Clinical Efficacy of Oligofructans from Ophiopogon japonicus in Reducing Atopic Dermatitis Flare-ups in Caucasian Patients. Acta Derm Venereol. 2019;99(10):858–864. https://doi.org/10.2340/00015555-3224.; Meinke MC, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Prevention of follicular penetration: barrier-enhancing formulations against the penetration of pollen allergens into hair follicles. Skin Pharmacol Physiol. 2011;24(3):144–150. https://doi.org/10.1159/000323018.; Lademann J, Patzelt A, Richter H, Schanzer S, Sterry W, Filbry A et al. Comparison of two in vitro models for the analysis of follicular penetration and its prevention by barrier emulsions. Eur J Pharm Biopharm. 2009;72(3):600–604. https://doi.org/10.1016/j.ejpb.2009.02.003.; Billmann-Eberwein C, Rippke F, Ruzicka T, Krutmann J. Modulation of atopy patch test reactions by topical treatment of human skin with a fatty acid-rich emollient. Skin Pharmacol Appl Skin Physiol. 2002;15(2):100–104. https://doi.org/10.1159/000049396.; Литовкина АО, Смольников ЕВ, Елисютина ОГ, Феденко ЕС. Современные эмоленты в профилактике обострений атопического дерматита в сезон цветения. Российский аллергологический журнал. 2023;20(1):41–51. https://doi.org/10.36691/RJA4136.; Luger T, Amagai M, Dreno B, Dagnelie MA, Liao W, Kabashima K et al. Atopic dermatitis: Role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci. 2021;102(3):142–157. https://doi.org/10.1016/j.jdermsci.2021.04.007.; Lowe AJ, Su JC, Allen KJ, Abramson MJ, Cranswick N, Robertson CF et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study. Br J Dermatol. 2018;178(1):e19–e21. https://doi.org/10.1111/bjd.15747
-
2Academic Journal
Συγγραφείς: Феденко Е.С., Захарова И.Н., Зайцева О.В., Пампура А.Н., Тамразова О.Б.
Πηγή: Российский аллергологический журнал
Θεματικοί όροι: atopic dermatitis, emollients, Epidermal barrier, pollen allergy, Cutaneous sensitization, атопический дерматит, эмоленты, эпидермальный барьер, пыльцевая аллергия, чрескожная сенсибилизация
Διαθεσιμότητα: https://repository.rudn.ru/records/article/record/105053/